Abstract
Despite optimal treatment, patients with soft tissue sarcoma are at risk for recurrence and therefore appropriate surveillance is critical. At minimum, regularly scheduled clinical assessments and chest X-rays are necessary. Consensus guidelines are available; however, surveillance strategies must be personalized based on the risk for recurrence and inherent disease biology. Further research is needed on a number of issues, including the impact of surveillance on clinical outcome and the utility of molecular surveillance. J. Surg. Oncol. 2015 111:641-645.
Original language | English (US) |
---|---|
Pages (from-to) | 641-645 |
Number of pages | 5 |
Journal | Journal of surgical oncology |
Volume | 111 |
Issue number | 5 |
DOIs | |
State | Published - Apr 1 2015 |
Keywords
- postoperative
- recurrence
- surveillance
ASJC Scopus subject areas
- Surgery
- Oncology